ANGPTL2 and cardiovascular disorder: Given that cardiac senescence is a potential driver of cardiovascular disease (Luan et al. 2024), these findings suggest that ANGPTL2‐mediated inflammation and cellular senescence contribute to HFD‐induced heart failure.